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Abstract 
Background: Long term conditions are on the rise and are associated with increased risk of 
psychological problems. Commonalities across long term conditions suggests a transdiagnostic 
psychological intervention may be beneficial.  An Acceptance and Commitment Therapy 
(ACT) group intervention was evaluated for people with long term physical health conditions. 
 
Methods: Participants with long term physical health conditions were invited to an ACT group 
(n=53). Measures were completed at assessment, pre, post and 3-month follow-up. These 
assessed anxiety and depression symptoms, health perceptions, values-based living and 
psychological flexibility. Period from assessment to pre intervention served as a within-
participant control. 
 
Results: Depression and anxiety symptoms reduced significantly from pre to post, compared 
to control period. Significant improvements were found in values-based living and 
psychological flexibility. These changes were in the context of non-significant changes in 
health perceptions.  
 
Conclusions: Group-based ACT interventions may be beneficial for long term physical 
conditions and can be delivered transdiagnostically. 
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Introduction 
Long term physical conditions (LTC) are a significant challenge for healthcare systems (Naylor 
et al., 2012).  Defined as those that require “ongoing management over a number of years or 
decades” (WHO, 2002, p. 11), there is widespread acknowledgement that the personal impact 
of LTC is greater than the physical symptoms alone (NHS Confederation, 2012). Individual 
experiences can vary, with some conditions being relatively stable (e.g. chronic low back pain) 
and others being progressive, such as multiple sclerosis, Alzheimer’s Disease or arthritis. 
Despite these differences, many people with LTC share common challenges, such as living 
with daily pain (DoH, 2012a) and difficulties performing everyday tasks (Hoffman, Rice & 
Sung, 1996). People with LTC are two to three times more likely to develop psychological 
problems such as depression, compared to the general population (Moussavi, Chatterji & 
Verdes, 2007).  
 
Traditional medical interventions aim to reduce and manage physical symptoms and enhance 
quality of life in LTC (Grumbach, 2003), but psychological interventions are increasingly 
playing an important role in the broader care of this population. Growing evidence suggests 
that psychological interventions such as cognitive behavioural therapy (CBT) can moderate the 
psychological impact of LTC across a range of conditions, such as multiple sclerosis (Mohr et 
al., 2001), human immunodeficiency virus (HIV; Markowitz et al., 1998), kidney disease 
(Duarte et al., 2009) and chronic obstructive pulmonary disease (Hynninen et al., 2001). The 
benefits of these interventions may not only be psychological: physical improvements in LTC, 
such as better glycemic control in diabetes (Alam et al., 2009) and reductions in pain (Vowles 
& McCracken, 2008) have also been reported following psychological intervention. 
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Much of this evidence is for single diagnoses, with each trial evaluating an intervention for an 
individual LTC. This diagnosis-specific approach, drawing on the medical model that 
underpins much of physical healthcare, is common in psychological intervention research 
(Taylor & Clark, 2009), with protocols often designed for specific psychiatric diagnosis 
populations such as panic disorder, unipolar depression or posttraumatic stress disorder (Butler, 
Chapman, Forman, & Beck, 2006). This approach has been criticised, however, and much of 
the critique is also relevant to psychological interventions in physical health settings (Mansell 
et al. 2009). For example, one important challenge for psychological research, in both mental 
health and chronic illness settings, is comorbidity.  More than half of those living with LTC 
have more than one condition, and this is set to rise (Barnett et al., 2012; Trento et al. 2012), 
yet the majority of research excludes participants with comorbid conditions (McManus et al., 
2010). Dissemination also presents a significant challenge to this approach, with therapists 
requiring training in many protocols in order to deliver evidence-based services (Taylor & 
Clark, 2009). Clearly, these challenges make it difficult to translate research to clinical 
populations (Barlow et al., 2004). 
 
Some researchers have responded by advocating a transdiagnostic or unified approach to 
psychological interventions (Barlow et al., 2004). Research linking emotion regulation 
processes such as rumination and avoidance to a wide range of psychiatric diagnoses 
(McLaughlin & Nolen-Hoeksema, 2012; Aldao, Nolen-Hoeksema & Schweizer, 2010) has led 
some to suggest therapies could be used across diagnoses with minimal adaptations (Taylor & 
Clark, 2009). Transdiagnostic approaches focus less on diagnostic differences and more on 
these shared underlying principles and processes. 
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Most transdiagnostic approaches have typically fallen into two broad categories. The first 
outlines interventions that could be delivered across a broad group of related diagnoses, such 
as mixed anxiety disorders (e.g. Norton & Hope, 2005), a range of eating disorders (Fairburn 
et al., 2003) and post-psychosis emotional dysfunction (White et al., 2011).  In physical health 
settings, examples include psychological interventions being used with a group of related 
physical diagnoses for bowel disorders (Drossman et al., 2003) and cardiac diseases (Elliot et 
al., 2014).  
 
The second category of transdiagnostic research proposes that psychological treatment can be 
applied across the majority of disorders with minimal adaptation. Examples include a cognitive 
behavioural therapy (CBT) protocol for a range of anxiety and depression disorders (McEvoy 
& Nathan, 2007). One psychological intervention model that fits particularly well with this 
category is Acceptance and Commitment Therapy (ACT; Hayes et al., 2011).  ACT has 
developed alongside a programme of basic research proposing a behaviour analytic theory of 
the influence of language and cognition on behaviour, called Relational Frame Theory (RFT; 
Hayes, Barnes-Holmes & Roche, 2001). Many of the central features of ACT are informed by 
an RFT analysis of the effect of cognition on behaviour. ACT considers that psychological 
disorder occurs when an individual tries to eliminate or reduce unpleasant internal experiences, 
such as distressing thoughts, emotions and sensations, even when doing so is likely to increase 
distress and limit their ability to lead a meaningful life (McCracken, 1998).  The ACT model 
refers to this as psychological inflexibility, and suggests that its influence over how humans 
respond can be a feature across psychological and physical disorders.  ACT interventions seek 
to develop more flexible responses, encouraging individuals to accept difficult or adverse 
experiences where doing so will enable a richer and more meaningful life. 
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Six overlapping and interdependent processes have been identified and are thought to 
contribute to psychological flexibility: acceptance (willingly allowing aversive experiences to 
occur, rather than avoiding them), cognitive defusion (ability to step back and separate oneself 
from cognitions, rather than becoming entangled with them), contact with the present moment 
(non-judgemental awareness of the present moment, contrasted with dominance of past or 
future events), values (clarity about personal values), committed action (acting in accordance 
with personal values, rather than in an attempt to reduce aversive experiences) and self-as-
context (a flexible repertoire of perspective-taking skills, rather than attachment to a dominant 
narrative about ourselves and others) (Hayes et al., 2006).  Techniques based on these 
processes aim to help individuals to become more flexible in their response to difficulties, and 
less reliant on avoiding these experiences.  
 
Evidence for ACT spans a range of populations, including physical health settings. Examples 
include chronic pain (Vowles & McCracken, 2008), diabetes (Gregg et al., 2007), epilepsy 
(Lundgren et al., 2006), cancer (Rost et al., 2012) and irritable bowel syndrome (Ferreira, 
2011). Much of this research takes a transdiagnostic approach by including a range of 
psychological comorbidities. One trial in a non-physical health setting has also reported 
evidence suggesting ACT is an effective intervention for a psychologically transdiagnostic 
group, which included anxiety and depression diagnoses (Forman et al. 2007).  
 
Psychological interventions in physical health settings are often delivered in group format and 
have a good evidence-base for LTC (Brassington et al., under review). Group psychological 
therapy encompasses a wide range of formats, ranging from a focus on psychodynamic 
interpersonal transactions (such as those based on Yalom’s (2005) group principles) to didactic 
psychoeducation interventions, with many interventions blending elements of both (Beiling, 
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McCabe and Antony, 2013) Evidence suggests that group therapy is as effective as individual 
therapy (Burlingame, Mackenzie & Strauss, 2004; Whitfield, 2010) and offers the potential for 
cost savings (Morrison, 2001; Tucker & Oei, 2007). In addition to this, group therapy offers 
additional benefits over an individual format, such as reducing social isolation and increasing 
learning opportunities through a wider range of interpersonal contacts (Bieling, McCabe & 
Antony, 2013).  It is unsurprising then that much ACT research has used group format in 
physical health settings. 
 
Research into ACT interventions has also considered the mechanisms of change that are 
important to outcomes. This is important as it helps us understand how the therapy works, how 
it can be further developed, and provides evidence for the scientific basis of the model (Hayes 
et al., 2006). A number of studies have reported such mediation analysis for ACT interventions 
in chronic health settings, highlighting acceptance processes as a mediator of outcome in 
patients with diabetes (Gregg et al., 2007), and valued living as a mediator in people with 
epilepsy (Lundgren, Dahl & Hayes, 2008). 
 
It is in this context that a novel ACT group intervention was developed for people with a range 
of LTC presenting to psychological health services in a U.K. National Health Service (NHS) 
setting. This study hypothesized that: (i) ACT would reduce psychological distress 
significantly relative to a control period in a physically and psychologically transdiagnostic 
group living with LTC, and (ii) valued living behaviours and psychological flexibility would 
mediate this outcome. 
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Methodology 
 
Participants 
Potential participants were identified by clinicians in a U.K. NHS Clinical Psychology 
department. Seventy-three individuals were invited to an eligibility interview with one of the 
two group facilitators (LB and PL). To be included, participants needed to be: aged 18 or over, 
English-speaking and have a long-term physical health condition (specified as having been 
present for a minimum of 12 months). For the purposes of this study, cancer was not included 
due to the difficulties classifying it as either acute or chronic, and whether long-term self-
management is required by sufferers. Participants were excluded if they had significant 
cognitive impairment, suicidal ideation or language or hearing difficulties, and instead received 
standard care.  Seven groups, with between four and nine participants, took place across two 
locations in an NHS trust. 
 
G*Power (Faul, Erdfelder, Lang & Buchner, 2008) was used to calculate a target sample size 
for this study. Literature to date has found large and medium effect sizes in condition-specific 
ACT intervention studies (e.g. Lundgren et al., 2006; Westin et al., 2007; Gregg et al., 2007; 
McCracken, Vowles, & Eccleston, 2005; Ferreira, 2011). A conservative medium effect size 
(f=.25) was predicted for this study, and calculations indicated a required sample size of 31 
group completers (α ≤ 0.05, β≥0.80). 
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Procedure 
A repeated measures design was used, with five outcome measures collected at 4 time points: 
baseline, immediately prior to session 1, end of session 6 and 3 month follow-up, as shown in 
Figure 1.  The period from T1 to T2 served as the control period. This approach was selected to 
control for treatment effects while also offering treatment to all participants within an 
acceptable timescale.  Referring clinicians were asked to discontinue individual appointments 
during the control and intervention periods where possible. Participants who failed to attend 
their eligibility interview were contacted and offered an alternative date. Similarly, if a 
participant missed a group session, they were offered the option of a group facilitator 
telephoning them to discuss the content and homework associated with the session they missed.  
Participants who attended less than 2 sessions of the group (one third of the intervention) were 
considered non-completers. Approval for this study was received from the East of Scotland 
Research Ethics Service. Potential participants were issued with an information leaflet about 
the study and gave informed consent. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: CONSORT flow chart 
T1 (0 weeks) 
T2 (+6 weeks) 
T3 (+12 weeks) 
T4 (+24 weeks) 
Excluded (n=20) 
Declined group (n=16) 
Unable to attend due to illness (n=4) 
Invited to group (n=53) 
Excluded (n=7) 
Did not attend group (n=6) 
Incomplete measures (n=1) 
Completed pre measures (n=46) 
Discontinued intervention (n=13) 
Dropped out after 1 session (n=3) 
Attended 2+ sessions but did not 
complete measures (n=10) 
Completed post measures (n=33) 
Lost to follow-up (n=11) 
Completed follow-up measures 
(n=22) 
Assessed for eligibility (n=73) 
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Measures 
Participants were asked to complete five questionnaires at each time point. The primary 
measure was selected to measure psychological distress. Secondary outcomes were two 
questionnaires to assess health status. Process measures included assessments of psychological 
flexibility and valued living, two key ACT processes.   
 
Psychological distress 
The primary outcome measure used was the Hospital Anxiety and Depression Scale (HADS, 
Zigmund & Snaith, 1983). The HADS is a brief, well-established and routinely used measure 
of symptoms of anxiety and depression with strong test-retest reliability (r>0.80; Spinhoven et 
al., 1997) and internal consistency (Cronbach α>0.75; Mykletun et al., 2001; Bjelland et al., 
2002). It is a self-report questionnaire containing 14 items and asks respondents to indicate the 
frequency that they have experienced each symptom over the previous seven days on a 4-point 
scale. Separate scores for anxiety and depression symptoms can be calculated, with higher 
scores corresponding to greater severity of symptoms. This measure, originally designed for 
medical outpatients, has been validated for use with a number of chronic health problems, 
including coronary heart disease (Stafford et al., 2007), myocardial infarction and stroke 
(Johnston et al., 2000) and multiple sclerosis (Honarmand & Feinstein, 2009). 
 
Health-related quality of life 
The RAND 36-item Health Survey 1.0 (SF-36; Ware & Shelbourne, 1992) is a self-report 
measure of health-related quality of life (HRQOL), based on the assumption that a number of 
health factors contribute to perception of HRQOL. To address this, the questionnaire assesses 
eight health domains: physical functioning, bodily pain, physical role limitations, emotional 
role limitations, emotional wellbeing, social functioning, energy / fatigue and health 
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perceptions. Responses are recoded and averaged within each of these health areas to produce 
scaled scores, with high scores indicating a more favourable quality of life. This widely-used 
questionnaire has strong reliability (Cronbach α ranging from 0.78 to 0.93), and validity across 
a number of health conditions, including hypertension, diabetes, congestive heart failure and 
myocardial infarction (McHorney et al., 1994). 
 
Illness perceptions 
The Brief Illness Perception Questionnaire (BIPQ; Broadbent et al., 2006) is an 8-item self-
report questionnaire with each question using an 11-point scale. The questions relate to 
perceptions about different aspects of health, from how long they expect their health problems 
to last, to how much control they feel they have over their illness.  As such, this provides a 
measure of participants’ cognitive evaluation of their health status. The authors suggest that 
three of the eight items are reverse scored to provide an overall score, and validation data across 
a number of health settings indicates good test-retest reliability and concurrent validity with a 
number of relevant measures (Cronbach α = 0.72; Løchting et al., 2013). 
 
Psychological flexibility 
To assess psychological flexibility as a general process, the Acceptance and Action 
Questionnaire II (AAQ-II; Bond et al., 2011) was included. This self-report questionnaire 
includes 7 statements rated on a 7-point Likert scale from “Never true” to “Always true”. 
Scores can be summed to produce an overall score, with higher scores indicating lower levels 
of acceptance and psychological flexibility. Reliability of this questionnaire is strong (mean α 
= 0.84) and its validity is well established via strong correlations with theoretically predicted 
other constructs, such as Beck Depression Inventory (r=0.71) and Symptom Checklist-90 
(0.70; Bond et al., 2011).  Illness-specific variations of this measure have been developed, but 
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due to the transdiagnostic nature of this intervention, the AAQ-II was considered to be the most 
appropriate. 
 
Valued living 
The Valuing Questionnaire (Smout et al., 2014), a 10-item self-report measure, was selected 
to assess changes in valued living. It asks respondents to rate statements on a scale from 0 
(“Not at all true”) to 6 (“Completely true”) with half of the items targeting progress towards 
living life in accordance with values (such as “I continued to get better at being the kind of 
person I want to be”), and the remainder targeting barriers and obstructions to this (for example, 
“It seemed like I was just ‘going through the motions’, rather than focusing on what was 
important to me”).  Separate scores for progress and obstruction can be summed, with higher 
scores on the progress scale indicating greater valued living behaviours, and higher obstruction 
scale scores indicating impaired valued-living.  The authors report good internal consistency 
(Cronbach α = 0.94) and correlations between both subscales and existing validated measures 
of psychological wellbeing and distress, respectively (r=0.19-0.70, Smout et al., 2014). 
 
Intervention 
The group intervention comprised weekly sessions for six weeks, lasting 2.5 hours (including 
a short break), plus two follow-up sessions one and three months later.  Groups were staggered 
across the year to mitigate any seasonal effects that could compound treatment effects. A 
treatment manual was developed by the authors based on existing evidence-based ACT 
protocols for specific physical health conditions such as irritable bowel syndrome and chronic 
pain (Ferreira & Gillanders, 2012; Vowles & McCracken, 2008; available on 
www.contextualscience.org/better_living_with_illness). As well as all of the ACT processes 
(cognitive defusion, present moment awareness, self as context, values, acceptance and 
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committed action), the protocol also included four additional elements to address common 
barriers to increasing behaviours in line with personal values for people living with LTC: 
problem solving skills, pacing to gradually improve function, assertive communication skills 
and goal setting. These elements were considered part of the therapy and were consistent with 
ACT in their delivery (e.g. pacing to increased valued behaviours rather than minimise aversive 
experiences such as pain).  
 
The manual focused on experiential exercises and the use of metaphors in accordance with the 
principles of the ACT model. Participants were provided with workbooks to use during and 
following group sessions (e.g. to structure homework and remind them of content and exercises 
covered) and a CD containing mindfulness exercises to facilitate practice of this skill outside 
of group sessions.  Table 1 outlines the content of the group sessions. 
 
Table 1: Session content of group 
Session Content 
1 Introductions and treatment rationale. Creative hopelessness exercises, 
including primary / secondary suffering and workability of coping 
strategies. 
2 Getting stuck with symptoms, thoughts and feelings versus moving 
forward with them using an experiential version of Passengers on the Bus 
metaphor1. An introduction to mindfulness. 
3 Clarification of personal values. 
4 Goal setting, cognitive defusion from thoughts and problem solving skills. 
5 Assertive communication skills, willingness and committing to action.  
6 Pacing, review of intervention and setback preparation. 
Follow ups Tailored to specific ongoing issues in making progress with goals. 
 
                                                 
1 Metaphor adapted from Hayes, Strohsal and Wilson (1999), accessed at 
http://onlinelibrary.wiley.com/store/10.1002/9781118499184.app3/asset/app3.pdf?v=1&t=i6g9tsdr&s=5b178d9f490701b0b4387
959ed88e4b65a30daa4 or available in the intervention protocol. 
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Facilitators of the group were a Health Psychologist (PL) with extensive experience delivering 
group psychological interventions, and a postgraduate doctoral student in clinical psychology 
(LB). Both facilitators received more than six days generic training in the ACT model, as well 
as two training sessions specific to this intervention.  This training included teaching, 
experiential exercises and role play covering the core exercises in the manual and discussion 
of scenarios that may occur in therapy. Supervision, including using audiotapes, comprised of 
at least two meetings per group with DG, a founder member of the Association for Contextual 
Behavioural Science, and NF, both experienced researchers and trainers of ACT, in addition to 
regular individual supervision with SY, an ACT-trained Clinical Psychologist with extensive 
experience working with people with LTC. 
Statistical Analyses 
Data analyses was conducted using Statistical Package for the Social Sciences (SPSS) version 
21.0. Data was checked for errors or missing data. Where missing data was less than 5%, mean 
imputation, case mean imputation (for individual questions) or sample mean imputation (for 
whole missing questionnaires) was used (Chavance, 2004).  Repeated measure ANOVAS with 
post-hoc Bonferroni adjusted pairwise comparisons were used to analyse results both for 
complete sets of pre-post data (using last-observation-carried-forward (LOCF), for participants 
lost to follow-up) alongside a more conservative intention-to-treat (ITT) method, with scores 
returning to pre-intervention (T2) level for participants who discontinued. Only participants 
who attended at least 2 sessions of the intervention were included in the analyses. Where 
Mauchly’s test showed that sphericity had been violated, Greenhouse-Geiser (if ε<.75) or 
Huynh-Feldt (if ε>.75) corrections were used.  Significant changes in the primary outcomes 
were predicted to be mediated by changes in psychological flexibility and valued living. As 
such, a mediation model with these processes as possible mediators was tested using an 
Ordinary Least Squares (OLS) method (Judd, Kenny & McClelland, 2001) for ITT data, with 
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scores returning to pre-intervention for drop-outs. Bootstrapping was used given the small 
sample size.  
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Results 
Preliminary Analyses 
Table 2: Participant characteristics  
Characteristic Completers (n=43) Non-completers (n=10) p 
Mean age in years (SD) 49.32 (12.17) 52.67 (16.93) 0.490 t 
Mean LTC duration in months (SD) 145.05 (118.64) 122.33 (157.29) 0.627 t 
Gender (%) 30 female (69.77%)  
13 male (30.23%) 
6 female (60.00%)  
4 male (40.00%) 
0.709 PC 
Ethnic (%) 
 White 
 Mixed 
 Missing 
 
38 (88.37%) 
1 (2.33%) 
4 (9.30%) 
 
7 (70.00%) 
0 (0.00%) 
3 (30.00%) 
0.848 PC 
Employment status (%) 
 Employed 
 Student 
 Unemployed 
 Retired 
 Missing 
 
15 (34.88%) 
1 (2.33%) 
15 (34.88%) 
8 (18.60%) 
4 (9.30%) 
 
2 (20.00%) 
0 
3 (30.00%) 
4 (40.00%) 
1 (10.00%) 
0.453 FE 
Marital status (%) 
 Married 
 Co-habiting 
 Single 
 Relationship 
 Widowed 
 
25 (58.14%) 
8 (18.60%) 
7 (16.28%) 
2 (4.65%) 
1 (2.33%) 
 
5 (50.00%) 
3 (30.00%) 
1 (10.00%) 
0 
1 (10.00%) 
0.654 FE 
Physical health condition (%) 
 Chronic pain 
 Neurological 
 Diabetes 
 Bowel 
 Osteological 
 Renal 
 Cardiological 
 Respiratory 
 Arthritis 
 Other 
 
13 (30.23%) 
9 (20.93%) 
5 (11.63%) 
5 (11.63%) 
2 (4.65%) 
3 (6.98%) 
1 (2.33%) 
0 
1 (2.33%) 
4 (9.30%) 
 
2 (20.00%) 
1 (10.00%) 
2 (20.00%) 
1 (10.00%) 
0 
0 
2 (20.00%) 
1 (10.00%) 
0 
1 (10.00%) 
0.321 FE 
 
NOTE: t=t-test; PC=Pearson Chi-square; FE=Fisher’s Exact test. 
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Table 3: Characteristics at baseline 
 Completers n= 43  
(Mean (SD)) 
Non-Completers n=10  
(Mean (SD)) 
p 
HADS  Depression 10.51 (4.35) 10.10 (2.77) 0.711 
HADS Anxiety 12.91 (4.31) 13.40 (2.07) 0.599 
AAQ-II 34.98 (10.34) 32.78 (9.59) 0.561 
VQ Progress 13.71 (7.24) 13.50 (5.08) 0.932 
VQ Obstruction 21.21 (6.18) 19.00 (4.14) 0.289 
BIPQ 58.57 (17.94) 52.40 (7.82) 0.295 
SF36 Physical 40.47 (32.47) 34.17 (23.40) 0.566 
SF36 Physical Limits 12.80 (25.69) 8.33 (12.50) 0.615 
SF36 Emotional Limits 17.89 (26.97) 22.22 (33.33) 0.677 
SF36 Fatigue 22.56 (16.31) 31.00 (23.66) 0.307 
SF36 Emotions 42.42 (19.87) 46.40 (18.40) 0.566 
SF36 Social 31.25 (23.30) 36.11 (28.26) 0.587 
SF36 Pain 32.50 (25.82) 30.83 (25.40) 0.861 
SF36 General 21.19 (17.43) 29.00 (23.07) 0.236 
 
 
Examination indicated that missing data was missing completely at random, with 0.57% of 
whole questionnaires missing, and a further 0.58% of individual questions missing. As such, 
mean imputation used to replace missing values (Chavance, 2004). The majority of variables 
were found to have normal distributions sufficient for assumptions of robust parametric tests 
(Field, 2009), with the exception of the Physical Limits, Emotional Limits, Fatigue and General 
subscales of the SF-36. Attempts to correct non-normal data were unsuccessful, and as such 
non-parametric tests were used for this data. 
 
Completers (those who attended two or more sessions) and non-completers did not differ 
significantly at baseline in terms of demographic characteristics or measures (see Tables 2 and 
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3). The average number of sessions attended by completers was 5.70 (SD=1.95; Mode=7). One 
participant received one individual session during the control period, and another received one 
individual session during the intervention period. Three participants received a telephone 
catchup for a missed session.  
 
Primary Analyses 
To investigate the first hypothesis of this study, repeated measures ANOVA analyses were 
conducted on HADS scores across the four time points for participants who completed post-
intervention measures at T3 (n=33). As predicted, significant reductions in HADS scores were 
found, with large effect sizes (see Table 4). Post-hoc comparisons in Table 5 indicated that 
there was no change in HADS scores during the control period (T1-T2), but found significant 
change in scores between pre- and post-intervention (T2-T3) with no significant difference 
between post-intervention and follow-up scores (T3-T4). Overall, this suggests that 
psychological distress reduced following intervention, and that these effects were maintained 
at 3-month follow-up. 
 
To control for a possible bias effect of excluding those who did not complete post-intervention 
measures, data was also analysed on an ITT basis with the conservative assumption that post 
treatment scores deteriorated to baseline levels (n=43). These results supported the completers 
analyses, with significant reductions in HADS scores with medium effect sizes (see Table 6). 
Post-hoc comparisons in Table 7 also highlighted no change in HADS scores during the control 
period (T1-T2), but significant reductions in scores between pre- and post-intervention (T2-T3) 
with no significant difference between post-intervention and follow-up scores (T3-T4). Overall, 
this further supports the hypothesis that psychological distress reduced following intervention, 
and that these effects were maintained at 3-month follow-up. 
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Table 4: Repeated measures ANOVA for pre-post completers# 
N=33 T1 
Baseline 
T2 
Pre 
T3 
Post 
T4 
Follow-up 
F p Effect size 
 
HADS   Depression 11.27 (4.09) 11.45 (4.09) 9.56 (4.89) 9.23 (4.82) 9.93 <0.001 .237 
 Anxiety 13.21 (3.95) 13.43 (3.52) 11.92 (4.10) 11.49 (3.61) 7.266 0.001g .185 
 Total 24.48 (7.13) 24.88 (6.93) 21.48 (8.59) 20.72 (7.68) 12.725 0.000 h  .285 
AAQ-II 36.16 (9.04) 35.72 (9.50) 31.61 (9.29) 33.48 (14.78) 3.043 0.056 g  .087 
VQ  Obstruction 22.40 (5.54) 20.35 (5.50) 19.06 (7.53) 17.99 (6.95) 6.033 0.002 h .159 
 Progress 12.23 (6.62) 13.26 (7.05) 16.19 (7.38) 16.29 (7.26) 6.393 0.001 .167 
BIPQ 60.02 (19.88) 57.39 (10.07) 53.73 (11.48) 52.85 (11.70) 3.259 0.061 g .092 
SF36  Physical 38.94 (29.76) 34.01 (28.52) 36.97 (28.14) 35.91 (28.12) 1.200 0.312 h .036 
 Physical 
Limits* 
9.11 (17.20) 4.77 (13.17) 21.97 (17.85) 21.97 (33.52) 11.507 0.009 .032 
 Emotional 
Limits* 
14.22 (23.25) 15.50 (30.04) 21.35 (16.88) 38.38 (42.59) 12.907 0.005 .038 
 Fatigue* 22.73 (15.96) 21.97 (17.85) 21.97 (32.93) 28.18 (21.71) 5.612 0.132 .007 
 Emotions 41.33 (19.64) 43.88 (20.38) 48.88 (19.74) 50.30 (19.82) 4.171 0.008 .115 
 Social 29.59 (20.64) 29.21 (24.20) 37.11 (25.67) 37.50 (28.47) 2.990 0.052 g .085 
 Pain 33.27 (24.59) 25.83 (21.88) 30.78 (24.37) 31.59 (23.67) 2.887 0.050 h .083 
 General* 20.86 (16.52) 21.35 (16.88) 23.14 (15.06) 25.15 (18.31) 2.416 0.491 <.001 
# Last observation carried forward used for missing follow-up data 
g Greenhouse-geisser adjusted significance levels used due to sphericity violation, where epsilon<0.75
 
h Huyhn-Felder adjusted significance levels used due to sphericity violation, where epsilon>0.75  
* Friedman’s ANOVA used as non-normal distribution, with r2 calculations for effect sizes 
NOTE: HADS=Hospital Anxiety and Depression Scale; AAQ-II=Acceptance and Action Questionnaire-II; VQ=Valuing Questionaire; SF36=Rand Short Form 36 
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Table 5: Post-hoc comparisons (pre-post completers)# 
    T1 vs T2    T2 vs T3    T3 vs T4 
N=33 MDiff
   
MDiff
   
MDiff
   
HADS   Depression -0.178 .006 1.888 .268** 0.333 .016 
 Anxiety -0.215 .007 1.509 .210** 0.424 .031 
 Total -0.393 .012 3.398 .328*** 0.758 .031 
AAQ-II 0.435 .004 4.116 .294** -1.879 .026 
VQ  Progress -1.023 .028 -2.930 .178* -0.106 .000 
 Obstruction 2.052 .139* 1.286 .054 1.070 .033 
BIPQ 2.628 .018 3.662 .158* 0.878 .020 
SF36 Physical 4.933 .090 -2.963 .049 1.061 .011 
 Physical Limits* 4.342 .008 -17.203 .058** 0.000 <.001 
 Emotional Limits* -1.281 <.001 -17.837 .036* -5.051 .005 
 Fatigue* 0.758 .005 -7.869 .024* 1.662 .003 
 Emotions -2.545 .029 -5.000 .112 -1.424 .010 
 Pain 7.436 .246** -4.948 .088 -0.810 .006 
 Social 0.379 .000 -7.895 .164* -0.391 .000 
 General -0.491 .005 -1.790 .005 -2.012 .002 
 
# Last observation carried forward used for missing follow-up data 
* p < .05; ** p < .01; *** p < .001 
* Post-hoc comparisons used Wilcoxon signed-rank teat as non-normal distribution, with r2 calculations for effect sizes 
NOTE: HADS=Hospital Anxiety and Depression Scale; AAQ-II=Acceptance and Action Questionnaire-II; VQ=Valuing 
Questionaire; SF36=Rand Short Form 36 
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Table 6: Repeated measures ANOVA (ITT) 
n=43 Baseline Mean 
(SD) 
Pre Mean 
(SD) 
Post Mean 
(SD) 
Follow-up 
Mean (SD) 
F p Effect size 
  
HADS   Depression 10.51 (4.34) 10.89 (4.29) 9.43 (4.77) 9.32 (4.54) 5.772 0.001 .121 
 Anxiety 12.91 (4.31) 13.10 (3.78) 11.94 (4.16) 11.77 (3.55) 4.954 0.005h .105 
 Total 23.42 (7.82) 23.98 (7.33) 21.37 (8.40) 21.09 (7.35) 7.643 0.000h .154 
AAQ-II 35.17 (10.29) 35.48 (9.25) 32.33 (9.17) 34.86 (13.54) 1.998 0.136g .045 
VQ  Progress 13.74 (7.07) 14.48 (7.41) 16.73 (7.38) 16.33 (7.49) 4.588 0.004 .098 
 Obstruction 21.21 (6.11) 20.43 (5.29) 19.44 (6.97) 18.34 (5.91) 3.438 0.025h .076 
BIPQ 58.80 (17.79) 57.02 (9.63) 54.21 (10.77) 53.93 (10.27) 2.541 0.101g .057 
SF36  Physical 40.47 (32.47) 35.40 (32.13) 37.67 (31.80) 36.51 (31.74) 2.203 0.100h .050 
 Physical Limits* 12.80 (25.07) 9.70 (24.33) 22.90 (34.73) 21.16 (34.36) 9.688 0.021 .024 
 Emotional Limits* 17.89 (26.32) 18.53 (32.59) 32.21 (41.52) 32.99 (42.47) 9.293 0.026 .022 
 Fatigue* 22.56 (16.31) 24.88 (19.59) 30.92 (22.34) 28.72 (20.56) 5.729 0.126 .008 
 Emotions 42.42 (19.87) 44.84 (21.16) 48.67 (20.62) 48.65 (21.18) 3.128 0.028 .069 
 Social 29.69 (21.27) 28.82 (24.06) 34.87 (25.52) 36.05 (26.89) 2.772 0.061g .062 
 Pain 32.51 (25.20) 28.90 (24.28) 32.69 (25.65) 32.15 (25.32) 1.343 0.263 .031 
 General* 12.62 (17.12) 22.31 (18.37) 23.69 (17.06) 24.53 (19.30) 1.320 0.724 .002 
g Greenhouse-geisser adjusted significance levels used due to sphericity violation, where epsilon<0.75 
h Huyhn-Felder adjusted significance levels used due to sphericity violation, where epsilon>0.75  
* Friedman’s ANOVA used as non-normal distribution, with r2 calculations for effect sizes 
NOTE: HADS=Hospital Anxiety and Depression Scale; AAQ-II=Acceptance and Action Questionnaire-II; VQ=Valuing Questionaire; SF36=Rand Short Form 36 
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Table 7: Post-hoc comparisons (ITT) 
N=43    T1 vs T2    T2 vs T3    T3 vs T4 
 MDiff 
 
MDiff 
 
MDiff 
 
HADS   Depression -0.369 .023 1.449 .206** 0.109 .001 
 Anxiety -0.118 .006 1.158 .161** 0.167 .004 
 Total -.558 .025 2.607 .252** .276 .003 
AAQ-II -0.317 .002 3.159 .225** -2.535 .050 
VQ  Progress -0.739 .015 -2.249 .137* 0.395 .004 
 Obstruction 0.784 .018 0.987 .042 1.100 .031 
BIPQ 1.784 .010 2.810 .121* 0.275 .002 
SF36 Physical 5.065 .109* -2.274 .038 1.163 .010 
 Physical Limits* 3.107 .008 -13.202 .058** 1.744 <.001 
 Emotional Limits* -0.639 <.001 -13.689 .036* -0.775 <.001 
 Fatigue* -2.326 .005 -6.040 .024* 2.202 .002 
 Emotions -2.419 .024 -3.838 .086 0.024 .000 
 Pain 3.614 .003 -3.797 .126 0.541 .004 
 Social 0.872 .060 -6.059 .068* -1.172 .002 
 General -.696 .005 -1.374 .005 -0.847 <.001 
* p < .05; ** p < .01; *** p < .001 
* Post-hoc comparisons used Wilcoxon signed-rank teat as non-normal distribution, with r2 calculations for effect sizes 
NOTE: HADS=Hospital Anxiety and Depression Scale; AAQ-II=Acceptance and Action Questionnaire-II; VQ=Valuing 
Questionaire; SF36=Rand Short Form 36 
 
Secondary Analyses 
Health status measures were also analysed, both for completers and using ITT. No significant 
change was found in illness perceptions (BIPQ) or health status (SF-36) using either approach 
to analysis, with change detected in only the physical limitations, emotional limitations and 
emotions domains of the SF-36 (see Tables 4 and 6).  However, these findings should be 
interpreted with caution given the large amount of variance in SF-36 scores.  Overall, this 
suggests that limitations to daily living improved following intervention, but that 
improvements in this and psychological distress occurred without improvements in overall 
health status or cognitive evaluation of health problems. 
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Process Analyses 
Analyses also suggested that both obstruction and progress VQ scores significantly changed 
over time, for both completers and ITT analysis with small to medium effect sizes (see Tables 
4 and 6). Post-hoc comparisons for progress scores indicated a significant improvement from 
pre- to post-intervention (T2-T3) with no change in the control period (T1-T2) or follow-up 
period (T3-T4) for completers and ITT analyses (see Table 5 & 7). However, comparisons for 
completers on the obstruction scale indicated a statistically significant improvement during the 
control period (T1-T2), but a non-significant improvement from pre- to post-intervention (T2-
T3) that continued into the follow-up period (T3-T4). Further, under ITT analyses, these findings 
reduced, with no significant differences between time points found (see Table 7). This suggests 
a general effect of time on VQ scores, but that the effect was a general trend rather than an 
effect relating to specific time periods. Taken together, this evidence gives preliminary support 
for valued living improvements following intervention. 
 
Measures of psychological flexibility were also subjected to completers and ITT analyses. 
Results indicated a small reduction in psychological inflexibility (AAQ-II) that approached 
significance (p=.056), in the completers analyses, with this near effect vanishing in the ITT 
data (see Tables 4 & 6). Inspection of post-hoc comparisons highlights a significant 
improvement in AAQ-II scores between pre- and post-intervention (T2-T3; see Table 5 & 7), 
with no change in the control period (T1-T2) or follow-up period (T3-T4). Overall, this suggests 
a more complex effect for this measure of psychological inflexibility, but that there was some 
change in this variable post-intervention. 
 
 
 24 
 
Mediation Analyses 
 
Table 8: Mediation analyses for AAQ-II and VQ Progress outcomes (pre-post ITT data) 
 
Dependent 
Variable Predictor R2 F Change p 
Bootstrapped standardized beta coefficients (β) 
Β t p β Confidence interval 
T2 HADS T2 AAQ-II 0.554 53.209 <.001 0.595 7.294 <.001 0.461 - 0.790 
T3 HADS T3 AAQ-II 0.622 70.030 <.001 0.728 0.067 <.001 0.599 - 0.866 
T3-T2 HADS 1) T3+T2 AAQ-II 0.236 1.042 .314 0.036 1.021 .289 -0.44 – 0.093 
2) T3-T2 AAQ-II 0.235 13.926 .001 0.388 3.748 .004 0.144 – 0.596 
T2 HADS T2 VQ Progress 0.495 42.096 <.001 0.704 6.488 <.001 0.521 - 0.887 
T3 HADS T3 VQ Progress 0.524 47.242 <.001 0.833 6.873 <.001 0.618 - 1.085 
T3-T2 HADS 1) T3+T2 VQ Progress 0.278 1.426 .239 0.052 1.194 .161 -0.14 - 0.130 
2) T3-T2 VQ Progress 0.271 16.590 <.001 0.428 4.100 .007 0.159 - 0.695 
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In order to assess whether changes in these process measures mediated change in the total 
HADS scores from pre- to post-intervention (T2-T3), a within-subjects mediation analysis was 
conducted as recommended by Judd, Kenny and McClelland (2001).  Judd and colleagues 
propose that a number of assumptions must first be met in order to complete mediation analysis 
on a within-subjects study.  
 
Firstly, there must be significant change between time points for both process and outcome 
variables. The findings reported in Table 7 indicate this is true for VQ Progress and 
psychological flexibility measures (AAQ-II), but not VQ Obstruction scores. Secondly, all 
measures must be scaled in the same direction, so that increases in outcome scores correspond 
to increases in process scores. The VQ Progress scale was reversed so that reduced scores 
indicated improvements in valued living.   
 
 As shown in Table 8, AAQ-II significantly predicted HADS scores at T2 (β=0.554, p<0.001) 
and T3 (β=0.728, p<0.001). Further, the mean difference for AAQ-II (T2-T3) significantly 
predicted the mean difference in HADS score for the same period (β=0.388, p=0.004), over the 
mean sum in AAQ-II (T2+T3) (β=0.036, p<0.289), indicating that improved psychological 
flexibility mediated the observed change in HADS scores in the ITT analyses. 
 
A similar pattern was found for VQ Progress scores, which significantly predicted HADS 
scores at T2 (β=0.704, p<0.001) and T3 (β=0.833, p<0.001). The mean difference for VQ 
Progress between these time points (T2-T3) also significantly predicted the mean difference in 
HADS score for the same period (β=0.428, p=0.007), over the mean sum of VQ Progress 
(T2+T3) (β=0.052, p<0.161), indicating that progress with valued living behaviours also 
mediated the observed change in HADS scores in the ITT analyses. 
 26 
 
 
Discussion 
The primary aim of this study was to develop and evaluate the effectiveness of an ACT group 
intervention for a transdiagnostic sample of patients living with LTC. Overall, the results 
support the use of this intervention and suggest that it is effective in reducing psychological 
distress. This conclusion was supported by medium to large effect sizes for these improvements 
and are broadly in line with similar research in clinical health outpatient settings (e.g. Vowles, 
Wetherell & Sorell, 2009; Gregg et al., 2007; McCracken, Sato & Taylor, 2013). There were 
similar benefits in the extent to which participants felt limited by their health problems, but 
limited change in cognitive evaluation of health problems and self-rated health status. This is 
consistent with the therapeutic aims of the intervention, with psychological improvements 
occurring in the context of no or limited change in health problems. 
 
In line with previous research, improvements in general psychological flexibility and progress 
with valued living mediated reductions in psychological distress (Vowles et al., 2014; Gregg 
et al., 2007; Ferreira, 2011; Lundgren, Dahl & Hayes, 2008). Many clinical health studies use 
illness-specific adaptations of psychological flexibility, rather than the general measure used 
in this study (e.g. diabetes: Gregg et al., 2007; chronic pain: McCracken, Vowles & Eccleston, 
2004; tinnitus: Westin, Hayes & Andersson, 2008).  Both general and illness-specific 
psychological flexibility have correlations with psychological distress, with general measures 
explaining additional variance independent of illness-specific measures (McCracken & Zhao-
O’Brien, 2010). Yet most research has used illness-specific measures of psychological 
flexibility in mediation analysis. A useful development for the future, therefore, might be a 
general adapted version of the AAQ that combines both general psychological flexibility and 
questions specific to health conditions, while maintaining a transdiagnostic stance to the latter. 
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While progress in valued living was highlighted as a mediator in the present study, it was 
somewhat surprising that obstructions to valued living did not also, particularly as this scale 
has strong correlations with psychological flexibility (Smout et al., 2014). One possible 
explanation for this is the qualitative difference between the progress and obstruction scales of 
the VQ. Whereas the progress scale measures improvements in valued living, the obstruction 
scale assesses ability to overcome barriers to progress. As the intervention was relatively brief, 
it is likely that such obstructions continued to be challenging for participants. Further, this 
measure is novel and not health specific, and the authors understand this to be the first trial of 
this measure in such a setting. As such, it may not have been sensitive to change with this 
population.  
 
Limitations and Strengths 
A number of limitations in this study should be noted. Although controlled, the present study 
had a modest sample size and was conducted as a pilot study without an active treatment 
comparison. The study relied on self-report measures which have a number of drawbacks, such 
as respondent fatigue and socially desirable responding (Hess, Hensher & Daly, 2012; Helmes 
and Holden, 2003).  They do however provide a practical, cost-effective way of measuring 
outcome and process. It would be useful for future research to use a broader but consistent 
range of measures. This should include aspects of general and health-specific psychological 
flexibility, as well as a range of ACT process-specific measures, such as the VQ and Cognitive 
Fusion Questionnaire (Gillanders et al., 2014). 
 
It is worth noting that diagnostic thresholds were not included in the eligibility criteria of this 
study, and as such, baseline levels of psychological distress varied with some participants 
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reporting below-threshold symptoms of anxiety and depression. Diagnostic thresholds in a 
transdiagnostic group present obvious challenges, with different psychological disorders 
having very different parameters for caseness.  This context of low baseline distress was not, 
however, a barrier to significant reductions in distress, and is consistent with how clinical 
settings may accept referrals to groups. Despite these limitations, the significant findings 
warrant further investigation in larger samples, with active treatment comparisons. 
 
The naturalistic approach of this study, operating in a clinical setting, is one of its key strengths 
and facilitates generalizability of the findings. The use of a controlled repeated measures design 
allowed conclusions to be drawn from a sample size that was realistic in a clinical setting but 
would have been insufficient for a randomized controlled study.  
 
Theoretical implications 
These findings are important in the context of the ongoing debate between the use of diagnosis-
specific and transdiagnostic approaches to research and psychological interventions. Health 
services are often organised by diagnosis, which can be a barrier to implementing 
transdiagnostic approaches (Mansell et al., 2009). So it is encouraging then that this 
transdiagnostic study was effectively integrated under such constraints. Much of the 
transdiagnostic research to date has focused on common processes, in particular which factors 
relate to a range of major psychological disorder categories (Levin et al., 2014). While this is 
important in setting the context for this work, it has become fragmented with a large number 
of inter-related processes implicated in a broad range of conditions (Aldao, Nolen-Hoeksema 
& Schweizer, 2010; Mansell et al., 2009). In contrast to this, psychological inflexibility as a 
transdiagnostic process has been described as a continuum or dimension that could contribute 
to most psychological disorders (Hayes et al., 2011), with a growing body of research 
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increasingly supporting this parsimonious approach (Levin et al., 2014; Brown & Barlow, 
2009). 
 
However, this is not to say that diagnostic approaches are not also without value. Trials 
comparing diagnosis-specific interventions with transdiagnostic ones are lacking. 
Transdiagnostic approaches need not be a replacement for diagnosis-specific interventions, and 
so are not required to outperform them (Clark, 2009). However, such comparisons would 
advance our understanding of when this approach is sufficient, and when a more specific 
approach is superior. Basic science findings may be more readily translated into diagnostic-
specific interventions, and so allowing both approaches to complement each other is likely to 
be advantageous (Craske, 2012). 
 
Clinical implications 
The benefits to using a transdiagnostic group approach in clinical health settings is wide 
ranging. As well as improvements in psychological distress and functioning, feedback from 
participants has been positive, suggesting high levels of treatment acceptability. This is an 
important aspect of services, and a more formal qualitative exploration of participants’ 
experiences would allow this to be investigated further.  
 
One important consideration in setting up a transdiagnostic group is agreeing the parameters 
for inclusion. Too broad a range in terms of severity of psychological difficulties risks 
polarization of group members, which can be an unhelpful dynamic for therapy (Söchting, 
2014). The range of physical conditions in a group is also likely to be an important factor for 
consideration. While there are many commonalities across living with different illnesses, some 
individual or diagnostic features are less common. For example, patients with terminal illness 
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are likely to face qualitatively different challenges to non-terminal chronic illness. For others, 
such as (HIV) and Hepatitis C, stigma is likely to be a factor in illness-associated distress 
(Vanable et al., 2006). Introducing such aspects into a mixed group could highlight differences 
between participants and alter the group process.   
 
Experience of this trial suggests that a transdiagnostic approach might not be appropriate for 
other reasons. In the U.K., physical conditions, such as chronic pain and oncology services, 
have more established group interventions available that can be tailored to be either diagnosis-
specific or specific to a broad diagnostic category. As Mansell et al. (2009) observes, there is 
little that a transdiagnostic approach can offer over and above tailored protocols here. There is 
also a danger of focusing on the commonalities across disorders at the expense of ignoring 
differences between diagnoses, which could be important targets for treatment and should be 
considered in a transdiagnostic intervention (Craske, 2012). Future research could explore 
characteristics of patients or conditions that are most likely to benefit from a transdiagnostic 
approach. 
 
Conclusions 
We would argue that transdiagnostic group psychological interventions can play an important 
role in services for people living with long term physical health conditions. Further research 
could help identify which patients are most likely to benefit from this approach and which 
would be more suitable for a diagnosis-specific or broad diagnostic category intervention.  This 
study comes at a time when there is increased interest and need to offer services to the 
population of people with LTC but with limited resources to allow for this extension (DoH, 
2012b). Clearly these findings are highly relevant and topical. 
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